Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934

For the month of June, 2024

Commission File Number: 333-249081

Curaleaf Holdings, Inc.
(Name of Registrant)

666 Burrard Street, Suite 1700,

Vancouver, British Columbia V6C 2X8, Canada
(Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☐ Form 40-F ☒

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


		CURALEAF HOLDINGS, INC.
		(Registrant)

Date:	June 14, 2024	By:	/s/ Peter Clateman
		Name:	Peter Clateman
		Title:	Chief Legal Officer

EXHIBIT INDEX


Exhibit Number						Description
99.1						Press Release
99.2						Report of Voting Results

Curaleaf Reports on Voting Results from the 2024 Annual General Meeting of Shareholders

NEW YORK, June 14, 2024 – The Annual General Meeting of Shareholders of Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, was held today via live webcast online. Each of the matters voted upon at the meeting is discussed in detail in the Company’s management information circular dated May 6, 2024 (the “Circular”), which can be found under the Company’s profile on SEDAR+ (www.sedarplus.ca) and on EDGAR (https://www.sec.gov/edgar).

The total number of votes cast by shareholders in person or represented by proxy at the meeting was 1,741,506,378 votes (with each subordinate voting share entitling the holder thereof to one vote, and each multiple voting share entitling the holder thereof to 15 votes). The voting results in relation to the election of directors were as follows:


	Percentage of Votes
Name of Director	For	Withheld
Boris Jordan	98.515	1.485
Joseph Lusardi	98.931	1.069
Dr. Jaswinder Grover	99.906	0.094
Karl Johansson	99.587	0.413
Peter Derby	99.253	0.747
Mitchell Kahn	98.736	1.264
Shasheen Shah	99.848	0.152
Michelle Bodner	98.873	1.127

In addition, the number of directors of the Company was also set by the shareholders of Curaleaf at 10 directors, and the resolution with respect to the reappointment of PKF O’Connor Davies, LLP as the Company’s auditor put before shareholders for consideration and approval at the meeting, as described in the Circular, was duly approved by the requisite number of votes. The Company has filed a report of voting results on all resolutions voted on at the meeting under its profile on www.sedarplus.ca and on www.sec.gov/edgar.

About Curaleaf Holdings

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.

Forward Looking Statements

This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or, "proposed", "is expected", "intends", "anticipates", or "believes",

119446644 v4

or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed on March 6, 2024, which is available under the Company's SEDAR+ profile at www.sedarplus.ca, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release.

INVESTOR CONTACT
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
IR@curaleaf.com

MEDIA CONTACT
Curaleaf Holdings, Inc.
Tracy Brady, SVP Corporate Communications
media@curaleaf.com

SOURCE Curaleaf Holdings, Inc.

119446644 v4

CURALEAF HOLDINGS, INC.

REPORT OF VOTING RESULTS

TO: British Columbia Securities Commission
Alberta Securities Commission
Financial and Consumer Affairs Authority of Saskatchewan

Manitoba Securities Commission

Ontario Securities Commission
Autorité des marchés financiers (Québec)
Financial and Consumer Services Commission (New Brunswick)
Nova Scotia Securities Commission
Financial and Consumer Services Division (Prince Edward Island)
Office of the Superintendent of Securities, Service Newfoundland and Labrador
Office of the Yukon Superintendent of Securities
Office of the Superintendent of Securities (Northwest Territories)
Office the Superintendent of Securities (Nunavut)

In accordance with Section 11.3 of National Instrument 51-102 – Continuous Disclosure Obligations, the following sets out the matters voted upon at the Annual General Meeting (the “Meeting”) of shareholders of Curaleaf Holdings, Inc. (the “Company”) held on June 14, 2024. Each of the matters set out below is described in greater detail in the Company’s Management Information Circular (the “Circular”) dated May 6, 2024.

1.Setting the Number of Directors

The number of directors was fixed at 10 directors. The results of the votes cast are set out below:


Votes For %			Votes Against %
99.760			0.240

2.Election of Directors

Each of the eight nominees listed in the Circular was elected as a director of the Company for the ensuing year or until their successor is elected or appointed. The results of the votes cast are set out below:


Nominee	Votes For %	Votes Withheld %
Boris Jordan	98.515	1.485
Joseph Lusardi	98.931	1.069
Dr. Jaswinder Grover	99.906	0.094
Karl Johansson	99.587	0.413
Peter Derby	99.253	0.747
Mitchell Kahn	98.736	1.264
Shasheen Shah	99.848	0.152
Michelle Bordner	98.873	1.127

119448970 v2

- 2 -

3.Appointment of Auditors

PKF O’Connor Davies, LLP was reappointed as the auditor of the Company until the next annual meeting of shareholders and the Board of Directors of the Company was authorized to fix the remuneration of the auditors. The results of the votes cast are set out below: